Publications by authors named "M Gard"

Tricuspid regurgitation (TR) is the most common pathology of the tricuspid valve (TV), with significant mortality in severe cases. A well-established strategy to treat TR is represented by the clover surgical technique, which consists of stitching together the free edges of TV leaflets, producing a clover-shaped valvular orifice. Transcatheter treatments for TR constitute a valuable alternative for high-risk patients.

View Article and Find Full Text PDF
Article Synopsis
  • Sclerotherapy is a treatment for chronic venous disease, but its effectiveness is often lower than thermal techniques; the study introduces a new three-balloon catheter for a method called empty vein ablation (EVA).
  • The study involved treating sheep jugular veins using EVA and foam sclerotherapy (FS), measuring how much of the vein's inner layer (intima) was affected and changes in thickness after treatment.
  • Results showed EVA achieved a lower remaining intact intima percentage compared to FS and caused more uniform damage along the vein, indicating that EVA might improve occlusion rates; however, in-vivo testing is needed to confirm these promising ex-vivo findings.
View Article and Find Full Text PDF

Glial scars have been observed following stab lesions in the spinal cord and brain but not observed and characterized in chemoconvulsant-induced epilepsy models. Epilepsy is a disorder characterized by spontaneous recurrent seizures and can be modeled in rodents. Diisopropylfluorophosphate (DFP) exposure, like other real-world organophosphate nerve agents (OPNAs) used in chemical warfare scenarios, can lead to the development of (SE).

View Article and Find Full Text PDF

Diisopropylfluorophosphate (DFP), an organophosphate nerve agent (OPNA), exposure causes status epilepticus (SE) and epileptogenesis. In this study, we tested the protective effects of saracatinib (AZD0530), a Src kinase inhibitor, in mixed-sex or male-only Sprague Dawley rats exposed to 4-5 mg/kg DFP followed by 2 mg/kg atropine and 25 mg/kg 2-pralidoxime. Midazolam (3 mg/kg) was given to the mixed-sex cohort (1 h post-DFP) and male-only cohort (~30 min post-DFP).

View Article and Find Full Text PDF